Our website uses necessary cookies to enable basic functions and optional cookies to help us to enhance your user experience. Learn more about our cookie policy by clicking "Learn More".
Accept All Only Necessary Cookies

GE Helpbot 정보

GE Helpbot

‘Augmented reality’ based access to learn about the latest GE Datex Ohmeda anesthesia machine and infant warmer devices. Understand the product features, benefits, DIY videos, installation, maintenance and troubleshooting suggestions. Switch between the augmented reality mode(LIVE) and 3D mode(OFFLINE) to learn more about the products in real time in the hospital setting or in the relaxed environs of your drawing room.

GE Datex Ohmeda launched a new Anesthesia Machine – 9100c NXT. Ever wanted a ready reckoner on your mobile that will help you understand more about the machine and aid in your routine work like changing the sodalime and troubleshoot errors? Your search ends here. This is app is suitable for anesthesiologists, CRNAs, nurses and biomed staff that provides:

• Key features and their benefits

• Troubleshooting suggestions to alarms

• Do it yourself videos – How to change flow sensors? How to replace soda lime in the canister?

• Preventive maintenance schedule

Lullaby Warmer Prime is an infant warmer that delivers exceptional thermoregulation while enhancing caregiver comfort. This ready reckoner for Doctors, Nursers, BioMeds provides:

• Key features and their benefits

• Troubleshooting suggestions to alarms

• Do it yourself videos – Packing, Installing and Configuring the product

• Preventive maintenance schedule

최신 버전 1.1의 새로운 기능

Last updated on Nov 24, 2017

Minor changes

번역 로드 중...

추가 앱 정보

최신 버전

GE Helpbot 업데이트 요청 1.1

업로드한 사람

Ahmađ AL Íssa

필요한 Android 버전

Android 4.4+

카테고리

무료 의료 앱

더 보기

GE Helpbot 스크린 샷

댓글 로드 중 ...
언어
APKPure를 구독하십시오
최고의 Android 게임 및 앱의 초기 릴리스, 뉴스 및 가이드에 액세스하는 첫 번째 사람이 되십시오.
고맙지 만 사양 할게
가입하기
성공적으로 구독!
당신은 이제 APKPure에 가입되었습니다.
APKPure를 구독하십시오
최고의 Android 게임 및 앱의 초기 릴리스, 뉴스 및 가이드에 액세스하는 첫 번째 사람이 되십시오.
고맙지 만 사양 할게
가입하기
성공!
당신은 이제 우리의 뉴스 레터를 구독하고 있습니다.